ConductScience.org, home

Paper702579

Alternative pathway activation in sickle cell disease and beta-thalassemia major.

deCiutiis AC and 3 others. J Natl Med Assoc, 1978. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Alternative pathway activation in sickle cell disease and beta-thalassemia major. Papers, record 702579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/702579

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alternative pathway activation in sickle cell disease and beta-thalassemia major.
PubMed
Journal
J Natl Med Assoc
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1deCiutiis ACA C
2Peterson CMC M
3Polley MJM J
4Metakis LJL J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, Sickle CellMajor topic
Complement ActivationMajor topic
Complement Pathway, AlternativeMajor topic
Sickle Cell TraitMajor topic
ThalassemiaMajor topic
Adolescent
Adult
Child
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11174692Iron metabolism, sickle cell disease, and response to cyanate.Blood1975https://conductscience.org/library/papers/1174692PubMed
24144343An abnormality of the alternate pathway of complement activation in sickle-cell disease.N Engl J Med1973https://conductscience.org/library/papers/4144343PubMed
34173567Progress in immunology. Syndromes of diminished resistance to infection.J Pediatr1968https://conductscience.org/library/papers/4173567PubMed
44262000The complement system of man (second of four parts).N Engl J Med1972https://conductscience.org/library/papers/4262000PubMed
54385710Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.N Engl J Med1968https://conductscience.org/library/papers/4385710PubMed
64400883Diplococcus pneumoniae infections in children with sickle cell anemia.Am J Dis Child1972https://conductscience.org/library/papers/4400883PubMed
74402312Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.J Immunol1972https://conductscience.org/library/papers/4402312PubMed
84403402Bactericidal and opsonic properties of C4-deficient guinea pig serum.J Immunol1972https://conductscience.org/library/papers/4403402PubMed
94813727Sodium cyanate as a potential treatment for sickle-cell disease.N Engl J Med1974https://conductscience.org/library/papers/4813727PubMed
104871700The importance of underlying disease in patients with gram-negative bacteremia.Arch Intern Med1968https://conductscience.org/library/papers/4871700PubMed
114897133Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.Medicine (Baltimore)1969https://conductscience.org/library/papers/4897133PubMed
124944120Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.Medicine (Baltimore)1971https://conductscience.org/library/papers/4944120PubMed
134951799Factors influencing host resistance to Salmonella infections: the effects of hemolysis and erythrophagocytosis.Am J Med Sci1967https://conductscience.org/library/papers/4951799PubMed
144987436Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency.N Engl J Med1970https://conductscience.org/library/papers/4987436PubMed
154987909Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.Immunology1970https://conductscience.org/library/papers/4987909PubMed
165063755An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.J Clin Pathol1972https://conductscience.org/library/papers/5063755PubMed
175466920Fulminant pneumococcemia and sickle cell anemia.JAMA1970https://conductscience.org/library/papers/5466920PubMed
185811425Functional asplenia in sickle-cell anemia.N Engl J Med1969https://conductscience.org/library/papers/5811425PubMed
195909733Pneumococcal meningitis in sickle-cell anemia.N Engl J Med1966https://conductscience.org/library/papers/5909733PubMed
206018771Hereditary deficiency of the second component of complement (C'2) in man: further observations on a second kindred.J Immunol1967https://conductscience.org/library/papers/6018771PubMed

See all 22 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41472508Proteomic Analysis of Golden Sputum Reveals Pulmonary Complement Activation During Acute Chest Syndrome in Children With Sickle Cell Disease.Am J Hematol2026https://conductscience.org/library/papers/41472508PubMed
39984047Emerging concepts in the molecular cell biology and functions of mammalian erythrocytes.J Biol Chem2025https://conductscience.org/library/papers/39984047PubMed
34889404Management of hemolytic transfusion reactions.Hematology Am Soc Hematol Educ Program2021https://conductscience.org/library/papers/34889404PubMed
33790681Complement in Sickle Cell Disease: Are We Ready for Prime Time?J Blood Med2021https://conductscience.org/library/papers/33790681PubMed
32695110Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs.Front Immunol2020https://conductscience.org/library/papers/32695110PubMed
24904418Heme on innate immunity and inflammation.Front Pharmacol2014https://conductscience.org/library/papers/24904418PubMed
16086799Development of complement therapeutics for inhibition of immune-mediated red cell destruction.Transfusion2005https://conductscience.org/library/papers/16086799PubMed
7690777Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.J Clin Invest1993https://conductscience.org/library/papers/7690777PubMed
7275323Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.Infect Immun1981https://conductscience.org/library/papers/7275323PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/702579

GET https://conductscience.org/api/papers/v1/702579/references?page=2